NPC1 and ovarian carcinoma: Compared to negative control (shNC), NPC1 knockdown significantly suppressed cell growth in MM (ARP-1), hepatocellular carcinoma (HepG2) and ovarian cancer (SKOV3) cells in vitro (Fig. 2A-D).